Understanding treatment tolerability in older patients with cancer
|Dates:||9/20/2018 - 8/31/2023|
|Role:||Marie Anne Flannery, PhD, RN : Co-Investigator|
|Principal Investigator:||Supriya Mohile|
The overarching goal of this U01 grant is to evaluate whether items from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) are associated with tolerability of treatment for advanced cancer in older patients with age-related conditions.